These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preparation and characterization of monoiodoinsulin. Linde S; Hansen B Int J Pept Protein Res; 1974; 6(3):157-63. PubMed ID: 4415172 [No Abstract] [Full Text] [Related]
5. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency. Sonne O; Linde S; Larsen TR; Gliemann J Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199 [TBL] [Abstract][Full Text] [Related]
6. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties. Linde S; Sonne O; Hansen B; Gliemann J Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):573-9. PubMed ID: 7024083 [TBL] [Abstract][Full Text] [Related]
7. Evidence for separate handling in vivo of different regions of the insulin molecule using A14- and B1-labeled insulin tracers. Cockram CS; Jones RH; Boroujerdi MA; Sönksen PH Diabetes; 1984 Aug; 33(8):721-7. PubMed ID: 6378697 [TBL] [Abstract][Full Text] [Related]
8. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity. Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587 [TBL] [Abstract][Full Text] [Related]
9. [Heterogeneity of the immunoreactivity of A14, A19, B16 and B26- (125I) monoiodoinsulin to different species of anti-insulin immuno sera]. Zhou W; Li S; Deng S Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):369-72. PubMed ID: 8150434 [TBL] [Abstract][Full Text] [Related]